CH675581A5 - - Google Patents

Download PDF

Info

Publication number
CH675581A5
CH675581A5 CH3117/86A CH311786A CH675581A5 CH 675581 A5 CH675581 A5 CH 675581A5 CH 3117/86 A CH3117/86 A CH 3117/86A CH 311786 A CH311786 A CH 311786A CH 675581 A5 CH675581 A5 CH 675581A5
Authority
CH
Switzerland
Prior art keywords
sep
acid addition
crystalline
zwitterion
mixture
Prior art date
Application number
CH3117/86A
Other languages
German (de)
English (en)
Inventor
Murray Kaplan
Thomas Hudyma
Robert Lipper
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CH675581A5 publication Critical patent/CH675581A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
CH3117/86A 1985-08-05 1986-08-04 CH675581A5 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (1)

Publication Number Publication Date
CH675581A5 true CH675581A5 (it) 1990-10-15

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3117/86A CH675581A5 (it) 1985-08-05 1986-08-04

Country Status (34)

Country Link
JP (1) JPH0615548B2 (it)
KR (1) KR930003121B1 (it)
AR (1) AR243894A1 (it)
AT (1) AT390957B (it)
AU (1) AU597262B2 (it)
BE (1) BE905219A (it)
CA (1) CA1284994C (it)
CH (1) CH675581A5 (it)
CS (2) CS276849B6 (it)
CY (1) CY1614A (it)
DD (2) DD254941A5 (it)
DE (1) DE3626375A1 (it)
DK (1) DK162053C (it)
EG (1) EG18003A (it)
ES (1) ES2002112A6 (it)
FI (1) FI84484C (it)
FR (1) FR2585705B1 (it)
GB (1) GB2179936B (it)
GR (1) GR862055B (it)
HK (1) HK99691A (it)
HU (1) HU196602B (it)
IE (1) IE59222B1 (it)
IL (1) IL79608A (it)
IT (1) IT1197067B (it)
LU (2) LU88574I2 (it)
MY (1) MY102212A (it)
NL (1) NL8601991A (it)
OA (1) OA08672A (it)
PT (1) PT83134B (it)
SE (1) SE469633B (it)
SG (1) SG79791G (it)
SU (1) SU1516013A3 (it)
YU (1) YU45793B (it)
ZA (1) ZA865842B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
DE3788279T2 (de) * 1987-06-25 1994-06-16 Banyu Pharma Co Ltd Kristalline cephalosporinzusammensetzungen, verfahren und zwischenprodukte für ihre herstellung.
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
US7592447B2 (en) 2003-12-23 2009-09-22 Sandoz Ag Process for production of intermediates for use in cefalosporin synthesis
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
HUT41802A (en) 1987-05-28
GB8618989D0 (en) 1986-09-17
AU597262B2 (en) 1990-05-31
SE469633B (sv) 1993-08-09
DD254941A5 (de) 1988-03-16
FI84484C (fi) 1991-12-10
LU86540A1 (fr) 1987-03-06
FR2585705B1 (fr) 1989-01-13
DK371886D0 (da) 1986-08-04
PT83134B (pt) 1989-07-31
MY102212A (en) 1992-05-15
AT390957B (de) 1990-07-25
CS276849B6 (en) 1992-08-12
IT1197067B (it) 1988-11-25
GB2179936A (en) 1987-03-18
ES2002112A6 (es) 1988-07-16
SE8603308D0 (sv) 1986-08-04
HK99691A (en) 1991-12-13
LU88574I2 (fr) 1995-03-01
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
DK371886A (da) 1987-02-06
DK162053C (da) 1992-02-10
EG18003A (en) 1991-08-30
ATA211086A (de) 1990-01-15
JPS62103090A (ja) 1987-05-13
YU137186A (en) 1987-12-31
AU6069486A (en) 1987-02-12
IE862078L (en) 1987-02-05
IT8621409A0 (it) 1986-08-04
SG79791G (en) 1991-11-15
IE59222B1 (en) 1994-01-26
SU1516013A3 (ru) 1989-10-15
FR2585705A1 (fr) 1987-02-06
BE905219A (fr) 1987-02-04
ZA865842B (en) 1987-04-29
AR243894A1 (es) 1993-09-30
FI84484B (fi) 1991-08-30
IL79608A (en) 1991-07-18
HU196602B (en) 1988-12-28
DE3626375A1 (de) 1987-02-12
NL8601991A (nl) 1987-03-02
IT8621409A1 (it) 1988-02-04
PT83134A (en) 1986-09-01
DK162053B (da) 1991-09-09
CA1284994C (en) 1991-06-18
CS276717B6 (en) 1992-08-12
OA08672A (en) 1989-03-31
IL79608A0 (en) 1986-11-30
CY1614A (en) 1992-07-10
FI863155A0 (fi) 1986-08-01
GR862055B (en) 1986-12-24
GB2179936B (en) 1989-04-26
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
DD268395A5 (de) 1989-05-31
YU45793B (sh) 1992-07-20
FI863155A (fi) 1987-02-06

Similar Documents

Publication Publication Date Title
DE3901359C2 (it)
DE3037102C2 (de) (6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)acetamido]-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylat-pentahydrat
AT392472B (de) Verfahren zur herstellung eines stabilen kristallinen di- oder trihydrats der 7beta- ((z)-2-(2-aminothiazol-4-yl)-4-carboxybut-2- enoylamino)-3-cephem-4-carbonsaeure
DE2332878C2 (de) Salze von Cephalosporinen mit Arginin und Lysin, ihre Herstellung und injizierbare pharmazeutische Zubereitungen
AT390957B (de) Verfahren zur herstellung neuer cephalosporinsalze
CH634578A5 (de) Verfahren zur herstellung von neuen cephalosporinderivaten.
DE1795292B2 (de) Cephalosporinderivate und Verfahren zu deren Herstellung
DE3037104C2 (de) Kristallines Bishydrochlorid von (6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oximino)acetamido]-3-(1-pyridiniummethyl)ceph-3-em-4-carboxylat
DD215552A5 (de) Verfahren zur herstellung von kristallisierten cephem-saeureadditionssalzen
EP0280157B1 (de) Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
DE3885031T2 (de) Wasserlösliches antibiotisches Präparat und wasserlösliche Salze von Cephem-Verbindungen.
DE2718730A1 (de) Cephalosporin-antibiotika
DE2614669C2 (de) Gamma-kristalline wasserfreie Form von 7-(D-alpha-Formyloxy-alpha-phenylacetamido)-3-(1-methyl-1H-tetrazol-5- ylthiomethyl)-3-cephem-4-natriumcarboxylat und Verfahren zu ihrer Herstellung
DE3740588A1 (de) Temperaturstabiles breitband-antibiotikum
DE3687171T2 (de) Kristallines triethylaminsalz von cefbuperazon.
AT393452B (de) Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
CH529789A (de) Verfahren zur Herstellung von kristallinem Cephalexinmonohydrat
DE2234280B2 (de) Cephalosporinverbindungen und Verfahren zu deren Herstellung
DE3786734T2 (de) Kristallines Additionssalz von Cephemcarboxylsäure.
DE2943437A1 (de) Cephalosporinverbindungen
DE1445844C (de) Salze mit dem Kation N(7-2-Thienylacetamidoceph-Sem-S-ylmethyO-pyridinium-4-carbonsäure und Verfahren zu deren Herstellung
DE2622985C3 (de) Antibiotisches Mittel enthaltend 7- [D-a-Amino-a-(p-hydroxyphenyl) acetamido] -3-il,2,3-triazol-5ylthiomethyl)-3- cephem-4-carbonsäure und Verfahren zu seiner Herstellung
DE2645144A1 (de) Cephalosporinverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
DE1445844B (de) Salze mit dem N- eckige Klammer auf 4-Carboxy-7-(2-thienylacetamido)-ceph-3-em-3ylmethyl eckige Klammer zu -pyridinium-Kation und Verfahren zu deren Herstellung
AT375663B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika

Legal Events

Date Code Title Description
SPCF Supplementary protection certificate filed

Free format text: REGISTRATION NO/DATE: IKS 52291, 950919

Spc suppl protection certif: C675581/01

Filing date: 19950919

SPCG Supplementary protection certificate granted

Free format text: REGISTRATION NO/DATE: IKS 52291/950223, 950919

Spc suppl protection certif: C675581/01

Filing date: 19950919

Extension date: 20100223

Effective date: 19960329

PL Patent ceased
SPCN Certificates - modification new representative

Free format text: FORMER REPRESENTANTIVE: E. BLUM AND CO. PATENTANWAELTE, CH

Spc suppl protection certif: C675581/01

Representative=s name: E. BLUM AND CO. AG PATENT- UND MARKENANWAELTE VSP

SPCN Certificates - modification new representative

Spc suppl protection certif: C675581/01

Representative=s name: BOVARD AG PATENTANWAELTE, CH

SPCL Supplementary protection certificate deletion

Spc suppl protection certif: C675581/01

SPCN Certificates - modification new representative

Free format text: VERTRETERLOESCHUNG

Spc suppl protection certif: C675581/01